Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06706726

To Evaluate the Effectiveness and Safety of Single-port Robotic-assisted Subcutaneous Gland Resection Combined With Immediate Breast Reconstruction in Breast Cancer

A Prospective, Single-center, Double-arm Clinical Study to Evaluate the Effectiveness and Safety of Single-port Robotic-assisted Subcutaneous Gland Resection Combined With Immediate Breast Reconstruction in Breast Cancer

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
The First Affiliated Hospital with Nanjing Medical University · Academic / Other
Sex
Female
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The new technology of robotic surgery system, as an emerging technology, has shown certain application prospects in breast surgery. However, the new technology of robotic surgery system in China in the treatment of breast cancer is still in the exploratory stage and needs to be further improved. This prospective, single-center, double-arm clinical study was conducted to use the single-port robot and evaluate the effectiveness and safety of the subcutaneous gland resection combined with immediate breast reconstruction in breast cancer.

Conditions

Interventions

TypeNameDescription
PROCEDUREsentinel lymph node biopsysentinel lymph node biopsy during the management of breast cancer
PROCEDURESingle-port robotic-assisted axillary lymph node dissectionSingle-port robotic-assisted(Endoscopic Instrument Control System SP1000) axillary lymph node dissection during the management of breast cancer

Timeline

Start date
2024-12-01
Primary completion
2026-12-31
Completion
2028-12-31
First posted
2024-11-27
Last updated
2024-11-29

Source: ClinicalTrials.gov record NCT06706726. Inclusion in this directory is not an endorsement.